$49.06
+3.42 (+7.49%)
At Close: Jun 03, 2026
EU regulator backs Moderna's updated COVID vaccine
11:41am, Friday, 25'th Jul 2025
The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the vaccine maker said on Friday.
Moderna (MRNA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:06am, Friday, 25'th Jul 2025
Moderna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Moderna's updated COVID-19 mRNA vaccine will be available for the 2025-2026 vaccination season, pending a European Commission authorization decision CAMBRIDGE, MA / ACCESS Newswire / July 25, 2025 / M
Moderna (MRNA) Stock Slides as Market Rises: Facts to Know Before You Trade
06:51pm, Thursday, 24'th Jul 2025
In the latest trading session, Moderna (MRNA) closed at $34.01, marking a -1.9% move from the previous day.
What's Going On With Moderna Stock Wednesday?
03:14pm, Wednesday, 23'rd Jul 2025
Moderna Inc.'s MRNA stock has surged approximately 37% in the last month but has dipped around 15% year to date.
How IBM and Moderna's partnership could lead to an explosion in drug development
12:31am, Saturday, 19'th Jul 2025
The two collaborated on research showing that quantum computing could greatly aid the design of mRNA-based medicines and treatments.
Here's Why Moderna (MRNA) Fell More Than Broader Market
06:51pm, Friday, 18'th Jul 2025
In the most recent trading session, Moderna (MRNA) closed at $31.25, indicating a -2.95% shift from the previous trading day.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:50am, Friday, 18'th Jul 2025
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Moderna cancels plans to build Japan plant on poor business environment
06:12am, Friday, 18'th Jul 2025
Moderna said on Friday it is cancelling plans to build a messenger RNA manufacturing plant in Japan due to "changes in the business environment" around the world and in Japan.
Moderna: Ready For The Redemption Arc
08:00am, Tuesday, 15'th Jul 2025
Moderna's stock has faced heavy pressure from negative headlines, regulatory setbacks, and political uncertainty, but recent FDA approvals have stabilized sentiment. The company now boasts three appro
Opinion: It's Time to Load Up on This Biotech Giant After Its 80% Crash
08:30pm, Monday, 14'th Jul 2025
It's difficult to get motivated about buying a stock that's plummeted or a company that seems to be out of favor with the general investment community. But if that company has bright long-term prospec
Moderna (MRNA) Suffers a Larger Drop Than the General Market: Key Insights
06:51pm, Friday, 11'th Jul 2025
The latest trading day saw Moderna (MRNA) settling at $33.64, representing a -1.87% change from its previous close.
MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients
12:01pm, Friday, 11'th Jul 2025
Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to 11 years.
This Former Meme Stock, Down 93%, is a High-Upside Buy Right Now
10:44am, Friday, 11'th Jul 2025
Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than three years ago.
Moderna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025
07:00am, Friday, 11'th Jul 2025
CAMBRIDGE, MA / ACCESS Newswire / July 11, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, August 1, 2025 to report i
Sign In
Buy MRNA